![leaphr-construction.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/mbW7GOOFx62Ncggd/leaphr-construction.com) |
leaphr-construction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leaphr-logistics.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/d6hUBUZZmpsZQQOg/leaphr-logistics.com) |
leaphr-logistics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Sep 2021 |
151 days |
|
![leapta-lifesciences.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/MWsWYIKESO5o08xQ0/leapta-lifesciences.com) |
leapta-lifesciences.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![microbiome-research.com](https://d363qos3mhnap4.cloudfront.net/serve/GbDNGOOF6N3S5t1H/microbiome-research.com) |
microbiome-research.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jul 2021 |
Jul 2021 |
One Off |
|
![hansonwade.com](https://dbsikz63q4tyx.cloudfront.net/serve/Jgk7YEETvktuvReR/hansonwade.com) |
mops-test.hansonwade.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![neo-antigen.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/IR9AYOLOevU0Dl7A/neo-antigen.com) |
neo-antigen.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![nononcologyraredisease-summit.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/tGnFPOOFRQQMz42z/nononcologyraredisease-summit.com) |
nononcologyraredisease-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jul 2021 |
77 days |
|
![nsclc-drug-development.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/8xaWZANYBE7ypbCe/nsclc-drug-development.com) |
nsclc-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
May 2021 |
Feb 2022 |
253 days |
|
![oligonucleotides-cvm.com](https://dbuflkpcdpfh3.cloudfront.net/serve/kogzWOOTs1K5maCf/oligonucleotides-cvm.com) |
oligonucleotides-cvm.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
May 2021 |
34 days |
|
![ras-drugdevelopment.com](https://dbsikz63q4tyx.cloudfront.net/serve/6BHZNOPEDRtoAmwr/ras-drugdevelopment.com) |
ras-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![operationalize-eap.com](https://dbuflkpcdpfh3.cloudfront.net/serve/yCC0NOPEuJWQf3AA/operationalize-eap.com) |
operationalize-eap.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![parp-ddr-inhibitors-summit.com](https://d1nywwyphm5jsu.cloudfront.net/serve/K6vuYARPDGbRiPIy/parp-ddr-inhibitors-summit.com) |
parp-ddr-inhibitors-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jul 2021 |
79 days |
|
![proteindegradation.com](https://d1nywwyphm5jsu.cloudfront.net/serve/qT3hZOOM9Mjld4ga/proteindegradation.com) |
proteindegradation.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![reformulate-edible-insects.com](https://dbsikz63q4tyx.cloudfront.net/serve/XUEnRADvbeXLci6/reformulate-edible-insects.com) |
reformulate-edible-insects.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
May 2021 |
May 2021 |
One Off |
|
![applied-biocatalysis-summit.com](https://d2uu9ep1796sii.cloudfront.net/serve/9RoIJAZZVgvAkLWO/applied-biocatalysis-summit.com) |
applied-biocatalysis-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![rnaibased-therapeutics.com](https://dbsikz63q4tyx.cloudfront.net/serve/VHsHPOOFYGLCsk55/rnaibased-therapeutics.com) |
rnaibased-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-connected-buildings.com](https://d2uu9ep1796sii.cloudfront.net/serve/G18ADUDELIjZhruQ/advancing-connected-buildings.com) |
advancing-connected-buildings.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jun 2021 |
50 days |
|
![advancing-construction-safety-operations.com](https://d2uu9ep1796sii.cloudfront.net/serve/4rRiDERP8cHqmXno/advancing-construction-safety-operations.com) |
advancing-construction-safety-operations.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jun 2021 |
Feb 2022 |
235 days |
|
![adc-targetselection.com](https://d2uu9ep1796sii.cloudfront.net/serve/eI9IDORKPLfN840c/adc-targetselection.com) |
adc-targetselection.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Aug 2021 |
Feb 2022 |
180 days |
|
![ai-drugdiscovery.com](https://d2uu9ep1796sii.cloudfront.net/serve/eDwVDORKJ1YBm4hI/ai-drugdiscovery.com) |
ai-drugdiscovery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Aug 2021 |
107 days |
|
![allogeneic-cell-therapies.com](https://d2uu9ep1796sii.cloudfront.net/serve/W5lXDUDEwWfZzZez/allogeneic-cell-therapies.com) |
allogeneic-cell-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![animal-gut-health-summit.com](https://d2uu9ep1796sii.cloudfront.net/serve/8M5KZANY6HqLWe5u/animal-gut-health-summit.com) |
animal-gut-health-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Dec 2021 |
Feb 2022 |
48 days |
|
![advanced-procurement-in-pharma.com](https://d2uu9ep1796sii.cloudfront.net/serve/qH9BNOPEXpcHUwJn/advanced-procurement-in-pharma.com) |
advanced-procurement-in-pharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-bridge-construction.com](https://d2uu9ep1796sii.cloudfront.net/serve/QmgzDERPmN7KCCZ3/advancing-bridge-construction.com) |
advancing-bridge-construction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jun 2021 |
51 days |
|
![automotive-cost-engineering.com](https://d2uu9ep1796sii.cloudfront.net/serve/gXHhYOLO7VQ12IQG/automotive-cost-engineering.com) |
automotive-cost-engineering.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jun 2021 |
53 days |
|
![tigit-therapies.com](https://deo39crpw7zzn.cloudfront.net/serve/0uN2WOOTL0mT2RK2/tigit-therapies.com) |
tigit-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![til-therapies.com](https://deo39crpw7zzn.cloudfront.net/serve/ilAgWOMPh6zucOGk/til-therapies.com) |
til-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![tnbc-summit.com](https://deo39crpw7zzn.cloudfront.net/serve/AZDlYOLO43o4zcfw/tnbc-summit.com) |
tnbc-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Dec 2021 |
229 days |
|
![tlr-prr-targeted-therapies.com](https://deo39crpw7zzn.cloudfront.net/serve/fjGUEPICtat8SkHu/tlr-prr-targeted-therapies.com) |
tlr-prr-targeted-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Dec 2021 |
Feb 2022 |
57 days |
|
![bcma-targeted-therapies.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/dFL8POOFemKQ1feO/bcma-targeted-therapies.com) |
bcma-targeted-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![tpd-beyond-oncology.com](https://deo39crpw7zzn.cloudfront.net/serve/dscJFIZZYlM5v8Im/tpd-beyond-oncology.com) |
tpd-beyond-oncology.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jan 2022 |
Feb 2022 |
9 days |
|
![biomarkerinsightssummit.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/J1xSBONKH91M85tk/biomarkerinsightssummit.com) |
biomarkerinsightssummit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![blood-brain-barrier-summit.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/vlhEEPICnD4KK0SP/blood-brain-barrier-summit.com) |
blood-brain-barrier-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jun 2021 |
61 days
|
|
![worldcdxeurope.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/eKOwDORKm3mKdQfC/worldcdxeurope.com) |
worldcdxeurope.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Dec 2021 |
233 days |
|
![cartcr-europe.com](https://d363qos3mhnap4.cloudfront.net/serve/4vMQDERPe2NTbAhK/cartcr-europe.com) |
cartcr-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![cdd-biologics.com](https://d363qos3mhnap4.cloudfront.net/serve/Tp9HZOOPNvupuJGh/cdd-biologics.com) |
cdd-biologics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![cdp-europe.com](https://d363qos3mhnap4.cloudfront.net/serve/WeptGOOFreu7AJ0o/cdp-europe.com) |
cdp-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Nov 2021 |
193 days |
|
![cell-therapies-infectious-diseases.com](https://d363qos3mhnap4.cloudfront.net/serve/es2pWACKtRwhUOVn/cell-therapies-infectious-diseases.com) |
cell-therapies-infectious-diseases.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Apr 2021 |
One Off |
|
![cytokine-immunotherapies.com](https://d363qos3mhnap4.cloudfront.net/serve/jlqAZOOPcPuE5zeI/cytokine-immunotherapies.com) |
cytokine-immunotherapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![decentralized-clinical-trials.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/nxxhYIKEStV7W5lD0/decentralized-clinical-trials.com) |
decentralized-clinical-trials.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![dermatology-drugdevelopment.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/s6zDZANYyhkahqno/dermatology-drugdevelopment.com) |
dermatology-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![engage-series-webinars.com](https://dbuflkpcdpfh3.cloudfront.net/serve/apQUWOMP1uFLQ4xZ/engage-series-webinars.com) |
engage-series-webinars.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![epigenetic-targets.com](https://dbuflkpcdpfh3.cloudfront.net/serve/NmAjFIZZw0Qjb0Uj/epigenetic-targets.com) |
epigenetic-targets.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![fermentation-enabled-proteins.com](https://d3nsmo0b6ncuv0.cloudfront.net/serve/CY95ZOOMQfV0NVZa/fermentation-enabled-proteins.com) |
fermentation-enabled-proteins.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![functionalprecisionmedicine.com](https://d3nsmo0b6ncuv0.cloudfront.net/serve/OONXDORKgi4f8YpT/functionalprecisionmedicine.com) |
functionalprecisionmedicine.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetherapy-immunogenicity.com](https://d1nywwyphm5jsu.cloudfront.net/serve/tFHnPOOF5LZohD3U/genetherapy-immunogenicity.com) |
genetherapy-immunogenicity.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetherapy-medical-affairs.com](https://d1nywwyphm5jsu.cloudfront.net/serve/mQHdGOOFFmIT0Lz9/genetherapy-medical-affairs.com) |
genetherapy-medical-affairs.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetherapy-neurological.com](https://d1nywwyphm5jsu.cloudfront.net/serve/gEGITACOpc1qSTij/genetherapy-neurological.com) |
genetherapy-neurological.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![hpapi-summit.com](https://dbsikz63q4tyx.cloudfront.net/serve/ySGiZOOM3uITAcpn/hpapi-summit.com) |
hpapi-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![inspire-facility-management.com](https://d2p0do391m6o41.cloudfront.net/serve/TvnfZOOPcIHL9AgM/inspire-facility-management.com) |
inspire-facility-management.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![jak-drugdevelopment.com](https://deo39crpw7zzn.cloudfront.net/serve/SndPWOMPDVh3eqHo/jak-drugdevelopment.com) |
jak-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leaphr-hospitality.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/5o2jYEETF85ZriC3/leaphr-hospitality.com) |
leaphr-hospitality.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![lbx-summit.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/8zqnZANYmYcHacbc/lbx-summit.com) |
lbx-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leap-hr-lifesciences-west.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/TckDHONKh98jIJo9/leap-hr-lifesciences-west.com) |
leap-hr-lifesciences-west.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Nov 2021 |
Feb 2022 |
75 days |
|
![leaphr-highereducation.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/U2ulZANY4KiMFn0Y/leaphr-highereducation.com) |
leaphr-highereducation.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leaphr-manufacturing.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/kjQgEPICKMQxQZeq/leaphr-manufacturing.com) |
leaphr-manufacturing.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leaphr-retail.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/t0VEBUZZe4cBe5Nz/leaphr-retail.com) |
leaphr-retail.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leaphr-searchlight.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/bLIxBEEPgZTpgtbe/leaphr-searchlight.com) |
leaphr-searchlight.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jul 2021 |
Feb 2022 |
213 days |
|
![leapta-lifesciences-europe.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/DonvZOOPQpKxwhzQ/leapta-lifesciences-europe.com) |
leapta-lifesciences-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
May 2021 |
28 days |
|
![manufacturing-assets-in-pharma.com](https://d363qos3mhnap4.cloudfront.net/serve/lqJ5FIZZxNH2COUN/manufacturing-assets-in-pharma.com) |
manufacturing-assets-in-pharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jan 2022 |
261 days |
|
![medicaldevice-software-development.com](https://d363qos3mhnap4.cloudfront.net/serve/SgLcWOMPP63SDEVG/medicaldevice-software-development.com) |
medicaldevice-software-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Sep 2021 |
Feb 2022 |
129 days |
|
![mrnabased-therapeutics.com](https://d363qos3mhnap4.cloudfront.net/serve/gHwoTACOWzYlFNn8/mrnabased-therapeutics.com) |
mrnabased-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
May 2021 |
Feb 2022 |
255 days |
|
![neuromuscular-drugdevelopment.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/SFW6NOPEKwDJ60RE/neuromuscular-drugdevelopment.com) |
neuromuscular-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jul 2021 |
Jul 2021 |
One Off |
|
![predict-innovation-drug-discovery.com](https://d1nywwyphm5jsu.cloudfront.net/serve/SVk5ZOOMWBqEtKGI/predict-innovation-drug-discovery.com) |
predict-innovation-drug-discovery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jan 2022 |
Feb 2022 |
19 days |
|
![predict-innovation-orthotopic-models.com](https://d1nywwyphm5jsu.cloudfront.net/serve/Bl3WYEETcR68RzEi/predict-innovation-orthotopic-models.com) |
predict-innovation-orthotopic-models.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Oct 2021 |
Feb 2022 |
122 days |
|
![produce-shelf-life-extension.com](https://d1nywwyphm5jsu.cloudfront.net/serve/RO5OMEOWbPb9jQxK/produce-shelf-life-extension.com) |
produce-shelf-life-extension.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
May 2021 |
36 days |
|
![prostatecancer-drugdevelopment.com](https://d1nywwyphm5jsu.cloudfront.net/serve/fCqvCOOLKfp2OVnG/prostatecancer-drugdevelopment.com) |
prostatecancer-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jul 2021 |
Aug 2021 |
46 days |
|
![rare-kidney-drug-development.com](https://dbsikz63q4tyx.cloudfront.net/serve/8pdBWOOT9D9RMOGe/rare-kidney-drug-development.com) |
rare-kidney-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Oct 2021 |
Feb 2022 |
120 days |
|
![ras-drugdiscovery.com](https://dbsikz63q4tyx.cloudfront.net/serve/iauGZOOMsu7RBPCC/ras-drugdiscovery.com) |
ras-drugdiscovery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![ards-summit.com](https://d2uu9ep1796sii.cloudfront.net/serve/0l0MWOOTt1hn0mte/ards-summit.com) |
ards-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-computational-design.com](https://d2uu9ep1796sii.cloudfront.net/serve/ISZ6YOLOEMtIHPkM/advancing-computational-design.com) |
advancing-computational-design.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-construction-quality.com](https://d2uu9ep1796sii.cloudfront.net/serve/fzjLYIKESgcrWp5YD/advancing-construction-quality.com) |
advancing-construction-quality.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-construction-safety-leadership.com](https://d2uu9ep1796sii.cloudfront.net/serve/i800YARPZEZo6eHs/advancing-construction-safety-leadership.com) |
advancing-construction-safety-leadership.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-enterprise-risk-management.com](https://d2uu9ep1796sii.cloudfront.net/serve/bo3eZOOPgrlzeWV7/advancing-enterprise-risk-management.com) |
advancing-enterprise-risk-management.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-project-controls.com](https://d2uu9ep1796sii.cloudfront.net/serve/a8SvYARPRLr8dy7v/advancing-project-controls.com) |
advancing-project-controls.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-sugar-reduction.com](https://d2uu9ep1796sii.cloudfront.net/serve/J10wCOOLT0KxCenI/advancing-sugar-reduction.com) |
advancing-sugar-reduction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Dec 2021 |
Feb 2022 |
49 days |
|
![advancing-construction-planning-scheduling.com](https://d2uu9ep1796sii.cloudfront.net/serve/x9OiBONKCTGSiyrg/advancing-construction-planning-scheduling.com) |
advancing-construction-planning-scheduling.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![anti-infectives-drug-development.com](https://d2uu9ep1796sii.cloudfront.net/serve/ZY7EBOOPr4jMYwap/anti-infectives-drug-development.com) |
anti-infectives-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![solid-tumors-summit.com](https://d2p0do391m6o41.cloudfront.net/serve/u4BfDUDEKupKXJMm/solid-tumors-summit.com) |
solid-tumors-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![synthetic-biology-therapeutics-summit.com](https://d2p0do391m6o41.cloudfront.net/serve/cVyMFUNKl7upkj1N/synthetic-biology-therapeutics-summit.com) |
synthetic-biology-therapeutics-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Dec 2021 |
Feb 2022 |
59 days |
|
![tgf-beta-summit.com](https://deo39crpw7zzn.cloudfront.net/serve/mhAMWACKc6E7Cpof/tgf-beta-summit.com) |
tgf-beta-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![tumor-models-sf.com](https://deo39crpw7zzn.cloudfront.net/serve/3R74RADrbPFQMUm/tumor-models-sf.com) |
tumor-models-sf.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![tumor-models.com](https://deo39crpw7zzn.cloudfront.net/serve/Ds4HZOOPyGdNNeus/tumor-models.com) |
tumor-models.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![tumor-myeloid-therapeutics.com](https://deo39crpw7zzn.cloudfront.net/serve/o52JROFLUoWF3DTP/tumor-myeloid-therapeutics.com) |
tumor-myeloid-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![tumour-models.com](https://deo39crpw7zzn.cloudfront.net/serve/BJ1ZMEOWQ0RbzzSA/tumour-models.com) |
tumour-models.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![biomarkers-alzheimers-disease.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/ZHFBMEOW16mF7WI1/biomarkers-alzheimers-disease.com) |
biomarkers-alzheimers-disease.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![bispecific.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/vcanRADbo2J4JPR/bispecific.com) |
bispecific.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![worldadc-asia.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/Ucp2FUNKRTthR4il/worldadc-asia.com) |
worldadc-asia.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![worldcdx-digital.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/CsdeWOMPvCt5z0B8/worldcdx-digital.com) |
worldcdx-digital.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![car-tcr-frontiers.com](https://d363qos3mhnap4.cloudfront.net/serve/6zlSYARPRb61jVSM/car-tcr-frontiers.com) |
car-tcr-frontiers.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Nov 2021 |
Feb 2022 |
93 days |
|
![cdx-europe.com](https://d363qos3mhnap4.cloudfront.net/serve/Zmx7YEETWNi42Do7/cdx-europe.com) |
cdx-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Feb 2022 |
Feb 2022 |
One Off |
|
![chronic-hbv-summit.com](https://d363qos3mhnap4.cloudfront.net/serve/ksKdWOOTDPhUvW8h/chronic-hbv-summit.com) |
chronic-hbv-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![complement-therapeutics.com](https://d363qos3mhnap4.cloudfront.net/serve/Dm0MZOOPRPKvfHLv/complement-therapeutics.com) |
complement-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![critical-assets-in-pharma.com](https://d363qos3mhnap4.cloudfront.net/serve/dqk4FIZZNoDV9are/critical-assets-in-pharma.com) |
critical-assets-in-pharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jun 2021 |
60 days |
|
![microbiome-nutrition.com](https://d363qos3mhnap4.cloudfront.net/serve/c9KMZANYcVviE7qj/microbiome-nutrition.com) |
microbiome-nutrition.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![microbiome-agbiotech.com](https://d363qos3mhnap4.cloudfront.net/serve/jEhNBEEPuwq20Kvo/microbiome-agbiotech.com) |
microbiome-agbiotech.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![exosomebased-tx.com](https://dbuflkpcdpfh3.cloudfront.net/serve/iAm7NOPEN99SNFdJ/exosomebased-tx.com) |
exosomebased-tx.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jan 2022 |
280 days |
|
![food-allergy-drugdevelopment.com](https://d3nsmo0b6ncuv0.cloudfront.net/serve/O3NqDUDEW2THEzEc/food-allergy-drugdevelopment.com) |
food-allergy-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Nov 2021 |
Feb 2022 |
85 days |
|
![genetherapy-muscular.com](https://d1nywwyphm5jsu.cloudfront.net/serve/HpTcEPICYWddDbVR/genetherapy-muscular.com) |
genetherapy-muscular.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetherapy-ophthalmology.com](https://d1nywwyphm5jsu.cloudfront.net/serve/KMBrNOPEcCk18oLA/genetherapy-ophthalmology.com) |
genetherapy-ophthalmology.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![gxp-cloudcompliance.com](https://d1nywwyphm5jsu.cloudfront.net/serve/jKuEBEEPcnxhfps5/gxp-cloudcompliance.com) |
gxp-cloudcompliance.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![gxpcompliance-optimization.com](https://d1nywwyphm5jsu.cloudfront.net/serve/mAVzDORKIjYMOJYe/gxpcompliance-optimization.com) |
gxpcompliance-optimization.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jan 2022 |
Feb 2022 |
33 days |
|
![leaphr-government.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/IFezTACOfzjWdbNd/leaphr-government.com) |
leaphr-government.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![head-and-neck-cancer-drug-development.com](https://dbsikz63q4tyx.cloudfront.net/serve/gwQoROFLWwAow9uA/head-and-neck-cancer-drug-development.com) |
head-and-neck-cancer-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Nov 2021 |
Feb 2022 |
82 days |
|
![industrializingcellbasedmeats.com](https://d2p0do391m6o41.cloudfront.net/serve/4XURYOLO3Vu3x0EI/industrializingcellbasedmeats.com) |
industrializingcellbasedmeats.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![innerear-disorders-therapeutics.com](https://d2p0do391m6o41.cloudfront.net/serve/qc58ZOOMiv3T8GMa/innerear-disorders-therapeutics.com) |
innerear-disorders-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
May 2021 |
Feb 2022 |
265 days |
|
![inspire-continuous-bioprocessing.com](https://d2p0do391m6o41.cloudfront.net/serve/X068YIKESeQZzXGXD/inspire-continuous-bioprocessing.com) |
inspire-continuous-bioprocessing.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![integrated-project-delivery.com](https://d2p0do391m6o41.cloudfront.net/serve/p95GBONKYezp45OA/integrated-project-delivery.com) |
integrated-project-delivery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![international-cdp.com](https://d2p0do391m6o41.cloudfront.net/serve/7lMoZOOPTwLHfRbY/international-cdp.com) |
international-cdp.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leaphr-financialservices.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/8TH5FUNKdBHL9DLS/leaphr-financialservices.com) |
leaphr-financialservices.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![car-tcr-summit.com](https://d363qos3mhnap4.cloudfront.net/serve/0UvzFUNKyq0Yqcv0/car-tcr-summit.com) |
car-tcr-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![microbiome-summit.com](https://d363qos3mhnap4.cloudfront.net/serve/bK2hBEEPCoeswK76/microbiome-summit.com) |
microbiome-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![gpcrs-drugdiscovery.com](https://d1nywwyphm5jsu.cloudfront.net/serve/7DNCBEEPUIk0g7CY/gpcrs-drugdiscovery.com) |
gpcrs-drugdiscovery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jan 2022 |
Feb 2022 |
33 days |
|
![rna-editing-summit.com](https://dbsikz63q4tyx.cloudfront.net/serve/hDh1MEOWzWGle2Bp/rna-editing-summit.com) |
rna-editing-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jun 2021 |
38 days |
|
![advancing-construction-operational-excellence.com](https://d2uu9ep1796sii.cloudfront.net/serve/8gvuWOOTlpeybWpp/advancing-construction-operational-excellence.com) |
advancing-construction-operational-excellence.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-aec-technology.com](https://d2uu9ep1796sii.cloudfront.net/serve/2uB6WACKgjwfYv4V/advancing-aec-technology.com) |
advancing-aec-technology.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-preconstruction.com](https://d2uu9ep1796sii.cloudfront.net/serve/Zw2oBONKZRtpk4GE/advancing-preconstruction.com) |
advancing-preconstruction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-prefabrication.com](https://d2uu9ep1796sii.cloudfront.net/serve/ARfpYOLOoH0Va11c/advancing-prefabrication.com) |
advancing-prefabrication.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![afdd-summit.com](https://d2uu9ep1796sii.cloudfront.net/serve/ao7UWOMPycITv26g/afdd-summit.com) |
afdd-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![ai-driven-drug-repositioning.com](https://d2uu9ep1796sii.cloudfront.net/serve/bLyXBEEPZQlHmZDe/ai-driven-drug-repositioning.com) |
ai-driven-drug-repositioning.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Oct 2021 |
188 days |
|
![sting-tlr-targeting-therapies.com](https://d2p0do391m6o41.cloudfront.net/serve/9P5OPOOFUUbk2DZD/sting-tlr-targeting-therapies.com) |
sting-tlr-targeting-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jun 2021 |
Feb 2022 |
244 days |
|
![supply-cell-immunotherapy.com](https://d2p0do391m6o41.cloudfront.net/serve/bdSMHONK9Ze79R4e/supply-cell-immunotherapy.com) |
supply-cell-immunotherapy.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![bacteriophage-summit.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/f2aLYIKESWx5HoyHU/bacteriophage-summit.com) |
bacteriophage-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![tpd-europe.com](https://deo39crpw7zzn.cloudfront.net/serve/3ZZlRADKfIEJgSE/tpd-europe.com) |
tpd-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![treg-directed-therapies.com](https://deo39crpw7zzn.cloudfront.net/serve/NbXnJAZZifUvma2v/treg-directed-therapies.com) |
treg-directed-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![wet-amd-drugdevelopment.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/u59ADUDEZlgL0U9a/wet-amd-drugdevelopment.com) |
wet-amd-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![world-cdx.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/wYCDYOLOqV46rdCe/world-cdx.com) |
world-cdx.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![worldadc-usa.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/GY65GOOFfUcFKEfB/worldadc-usa.com) |
worldadc-usa.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leaphr-healthcare.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/3FJeCOOLYrPnmzYZ/leaphr-healthcare.com) |
leaphr-healthcare.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![celltherapy-diabetes.com](https://d363qos3mhnap4.cloudfront.net/serve/ORT3GOOFdSVtk08l/celltherapy-diabetes.com) |
celltherapy-diabetes.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jun 2021 |
58 days |
|
![ckd3-summit.com](https://d363qos3mhnap4.cloudfront.net/serve/ITZyYOLOkbw0jOye/ckd3-summit.com) |
ckd3-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![clinicallyvalidated-dtx.com](https://d363qos3mhnap4.cloudfront.net/serve/CvnTWOMPoatADReT/clinicallyvalidated-dtx.com) |
clinicallyvalidated-dtx.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![commercializing-flow-chemistry.com](https://d363qos3mhnap4.cloudfront.net/serve/PuSoEPICKXM6xjyp/commercializing-flow-chemistry.com) |
commercializing-flow-chemistry.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![continuous-processing-pharma.com](https://d363qos3mhnap4.cloudfront.net/serve/tRu3JAZZFTWC1M2y/continuous-processing-pharma.com) |
continuous-processing-pharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![crispr-agbio.com](https://d363qos3mhnap4.cloudfront.net/serve/mSloGOOFRhevG00B/crispr-agbio.com) |
crispr-agbio.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Aug 2021 |
123 days |
|
![crispr-conference.com](https://d363qos3mhnap4.cloudfront.net/serve/XaEdRADbTLJs9md/crispr-conference.com) |
crispr-conference.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jul 2021 |
Feb 2022 |
214 days |
|
![dry-amd-therapeutics.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/MFNPDUCKHVFUF0jJ/dry-amd-therapeutics.com) |
dry-amd-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![fcrn-targeted-therapeutics.com](https://d3nsmo0b6ncuv0.cloudfront.net/serve/gXFkYOLO3zyDPicq/fcrn-targeted-therapeutics.com) |
fcrn-targeted-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Sep 2021 |
133 days |
|
![gamma-delta-t-therapies.com](https://d1nywwyphm5jsu.cloudfront.net/serve/winqDERPsoS1qeMa/gamma-delta-t-therapies.com) |
gamma-delta-t-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetherapy-analytical.com](https://d1nywwyphm5jsu.cloudfront.net/serve/3h0JEPICu4KzRF1M/genetherapy-analytical.com) |
genetherapy-analytical.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetherapy-blood.com](https://d1nywwyphm5jsu.cloudfront.net/serve/BMHgMEOWDP3a8dJm/genetherapy-blood.com) |
genetherapy-blood.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetherapy-europe.com](https://d1nywwyphm5jsu.cloudfront.net/serve/bAVtBEEPWVF8dcKq/genetherapy-europe.com) |
genetherapy-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetherapy-neurological-europe.com](https://d1nywwyphm5jsu.cloudfront.net/serve/QrEBDERPwShgoHYA/genetherapy-neurological-europe.com) |
genetherapy-neurological-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetic-vaccine-analytical-development.com](https://d1nywwyphm5jsu.cloudfront.net/serve/qwPfYARPDfujFQeN/genetic-vaccine-analytical-development.com) |
genetic-vaccine-analytical-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jan 2022 |
Feb 2022 |
34 days |
|
![genetic-vaccine-development.com](https://d1nywwyphm5jsu.cloudfront.net/serve/2wxmDUDEzFGVqYby/genetic-vaccine-development.com) |
genetic-vaccine-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![hansonwade.com](https://dbsikz63q4tyx.cloudfront.net/serve/Jgk7YEETvktuvReR/hansonwade.com) |
hansonwade.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![hfpef-summit.com](https://dbsikz63q4tyx.cloudfront.net/serve/CjDoWOMPvTq9jlXP/hfpef-summit.com) |
hfpef-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jan 2022 |
Feb 2022 |
32 days |
|
![ild-summit.com](https://d2p0do391m6o41.cloudfront.net/serve/x1PHBONKkpzojX0K/ild-summit.com) |
ild-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![inflammasome-therapeutics.com](https://d2p0do391m6o41.cloudfront.net/serve/LTxfHONKXVx9bA2H/inflammasome-therapeutics.com) |
inflammasome-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![ipsc-therapies-summit.com](https://d2p0do391m6o41.cloudfront.net/serve/JjqIYEETq17lylUI/ipsc-therapies-summit.com) |
ipsc-therapies-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Sep 2021 |
Feb 2022 |
141 days |
|
![ipf-summit.com](https://d2p0do391m6o41.cloudfront.net/serve/X0keYIKESdxyQMgk4/ipf-summit.com) |
ipf-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![lag3-drugdevelopment.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/FaGlJAZZkb3BASG4/lag3-drugdevelopment.com) |
lag3-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Nov 2021 |
Feb 2022 |
76 days |
|
![leap-tech-talent.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/6S6cZOOM5TqLDURN/leap-tech-talent.com) |
leap-tech-talent.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leaphr-emerging-biopharma.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/LPDZBEEPjs8cOddg/leaphr-emerging-biopharma.com) |
leaphr-emerging-biopharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leaphr-healthcare-webinar.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/XnJUEPIC3HJd1iuX/leaphr-healthcare-webinar.com) |
leaphr-healthcare-webinar.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Sep 2021 |
Feb 2022 |
135 days |
|
![leaphr-lifesciences-europe.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/zAzuBEEPvtdME2gO/leaphr-lifesciences-europe.com) |
leaphr-lifesciences-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![lifesciences-fpa-summit.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/oUg5ROFLuIqelWWS/lifesciences-fpa-summit.com) |
lifesciences-fpa-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
May 2021 |
Feb 2022 |
258 days |
|
![longevity-therapeutics.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/ypK0WOMPu1khIm9x/longevity-therapeutics.com) |
longevity-therapeutics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![microbiome-advanced-models.com](https://d363qos3mhnap4.cloudfront.net/serve/y5b3YARPS86baM60/microbiome-advanced-models.com) |
microbiome-advanced-models.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Sep 2021 |
Feb 2022 |
128 days |
|
![microbiome-dermatology.com](https://d363qos3mhnap4.cloudfront.net/serve/3PQzCOOLDJgCyDGK/microbiome-dermatology.com) |
microbiome-dermatology.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![microbiome-europe.com](https://d363qos3mhnap4.cloudfront.net/serve/dz2KBUZZarWg4snP/microbiome-europe.com) |
microbiome-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![microbiome-movement-asia.com](https://d363qos3mhnap4.cloudfront.net/serve/8zOcZANY8uk997vJ/microbiome-movement-asia.com) |
microbiome-movement-asia.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![nash-summit.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/Lx8wBORKLo4rHKte/nash-summit.com) |
nash-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![neurodegenerative-drug-development.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/OUwnGOOFJ0abJc5L/neurodegenerative-drug-development.com) |
neurodegenerative-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![neuroimmunology-drugdevelopment.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/fccbRADBKbFxAOs/neuroimmunology-drugdevelopment.com) |
neuroimmunology-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![next-gen-genetherapy-vectors.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/Kv9zWOMPoYiWo6WN/next-gen-genetherapy-vectors.com) |
next-gen-genetherapy-vectors.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![oligonucleotides-cns.com](https://dbuflkpcdpfh3.cloudfront.net/serve/oKi6TACOlyvDKYIv/oligonucleotides-cns.com) |
oligonucleotides-cns.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-design-quality-management.com](https://d2uu9ep1796sii.cloudfront.net/serve/gIVqTACOSKSSof64/advancing-design-quality-management.com) |
advancing-design-quality-management.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jan 2022 |
Feb 2022 |
5 days |
|
![rna-drugdiscovery.com](https://dbsikz63q4tyx.cloudfront.net/serve/6Uj6ZOOMmHqDvkBZ/rna-drugdiscovery.com) |
rna-drugdiscovery.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![rnaediting-summit.com](https://dbsikz63q4tyx.cloudfront.net/serve/c5mfZANYlgrFNeZJ/rnaediting-summit.com) |
rnaediting-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jan 2022 |
Feb 2022 |
17 days |
|
![rsv-drug-development.com](https://dbsikz63q4tyx.cloudfront.net/serve/vKmpCOOLKXg8TnIP/rsv-drug-development.com) |
rsv-drug-development.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Oct 2021 |
Feb 2022 |
118 days |
|
![advancing-data-center-construction.com](https://d2uu9ep1796sii.cloudfront.net/serve/kpOpWOOT9ZKTALEF/advancing-data-center-construction.com) |
advancing-data-center-construction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-mass-timber.com](https://d2uu9ep1796sii.cloudfront.net/serve/2MddDORKy5Klu9SS/advancing-mass-timber.com) |
advancing-mass-timber.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-construction-analytics.com](https://d2uu9ep1796sii.cloudfront.net/serve/NTTZJAZZNKcHUDGz/advancing-construction-analytics.com) |
advancing-construction-analytics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![advancing-prefabrication-biopharma.com](https://d2uu9ep1796sii.cloudfront.net/serve/A4HpROFL493OsOM0/advancing-prefabrication-biopharma.com) |
advancing-prefabrication-biopharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jun 2021 |
51 days |
|
![strategic-operational-excellence-lifesciences.com](https://d2p0do391m6o41.cloudfront.net/serve/mO0gDORKRTqnympv/strategic-operational-excellence-lifesciences.com) |
strategic-operational-excellence-lifesciences.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Jun 2021 |
Feb 2022 |
244 days |
|
![targeted-radiopharma.com](https://deo39crpw7zzn.cloudfront.net/serve/awLvYARPJ6W5nXqE/targeted-radiopharma.com) |
targeted-radiopharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![tcr-therapies-summit.com](https://deo39crpw7zzn.cloudfront.net/serve/nBj5YIKES80IMl1HP/tcr-therapies-summit.com) |
tcr-therapies-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![autoimmunity-modeling.com](https://d2uu9ep1796sii.cloudfront.net/serve/dSuZJAZZDhQpn4kB/autoimmunity-modeling.com) |
autoimmunity-modeling.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![beacon-intelligence.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/ymaMWOMPzokTQ8B2/beacon-intelligence.com) |
beacon-intelligence.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jun 2021 |
59 days |
|
![biobased-alternative-materials.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/YA4JROFLJ0XmlIzx/biobased-alternative-materials.com) |
biobased-alternative-materials.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![worldadc-awards.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/Y2z4ROFLdk6LXIVO/worldadc-awards.com) |
worldadc-awards.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![worldadc-digital.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/np90EPICN7P2VyM5/worldadc-digital.com) |
worldadc-digital.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![worldadc-europe.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/7DkBBEEPPY53C7Ip/worldadc-europe.com) |
worldadc-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![car-tcr-celltx-launch.com](https://d363qos3mhnap4.cloudfront.net/serve/TPnfBEEPOTl246pn/car-tcr-celltx-launch.com) |
car-tcr-celltx-launch.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Feb 2022 |
Feb 2022 |
One Off |
|
![cell-engager-summit.com](https://d363qos3mhnap4.cloudfront.net/serve/ogvhDERP54dIbRUF/cell-engager-summit.com) |
cell-engager-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![cell-therapy-analytics.com](https://d363qos3mhnap4.cloudfront.net/serve/YAjWTACOY7KiQVnp/cell-therapy-analytics.com) |
cell-therapy-analytics.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![ddr-inhibitors-summit.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/hjKdYEET5biyWUOc/ddr-inhibitors-summit.com) |
ddr-inhibitors-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Nov 2021 |
Feb 2022 |
90 days |
|
![engage-series.com](https://dbuflkpcdpfh3.cloudfront.net/serve/xk18YEETADT9LCO3/engage-series.com) |
engage-series.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetherapy-analytical-europe.com](https://d1nywwyphm5jsu.cloudfront.net/serve/PIOgCOOLpKsuAhGn/genetherapy-analytical-europe.com) |
genetherapy-analytical-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetherapy-conference.com](https://d1nywwyphm5jsu.cloudfront.net/serve/YjBuDERPGGTrg1WQ/genetherapy-conference.com) |
genetherapy-conference.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![genetherapy-metabolic.com](https://d1nywwyphm5jsu.cloudfront.net/serve/GtsuWACKbgGIrzlE/genetherapy-metabolic.com) |
genetherapy-metabolic.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jul 2021 |
87 days |
|
![genetherapy-comparability.com](https://d1nywwyphm5jsu.cloudfront.net/serve/voSJEPICb5h3IB5q/genetherapy-comparability.com) |
genetherapy-comparability.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![glioblastoma-drugdevelopment.com](https://d1nywwyphm5jsu.cloudfront.net/serve/f2uzYIKESzDxrC64x/glioblastoma-drugdevelopment.com) |
glioblastoma-drugdevelopment.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![inborn-errors.com](https://d2p0do391m6o41.cloudfront.net/serve/ovesROFL1W2TKWw8/inborn-errors.com) |
inborn-errors.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Jul 2021 |
95 days |
|
![innate-killer.com](https://d2p0do391m6o41.cloudfront.net/serve/25fvDUDEYFRpzqRK/innate-killer.com) |
innate-killer.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![lab-asset-in-pharma.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/IWXFYOLOXouu77Ot/lab-asset-in-pharma.com) |
lab-asset-in-pharma.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leaphr-future-energy.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/7VZmHONKdyrW7rHd/leaphr-future-energy.com) |
leaphr-future-energy.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leaphr-life-sciences-fall.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/NuDaFIZZFdG4gSM9/leaphr-life-sciences-fall.com) |
leaphr-life-sciences-fall.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Aug 2021 |
104 days |
|
![leaphr-lifesciences-spring.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/5SAYBOOPvv7F3jOr/leaphr-lifesciences-spring.com) |
leaphr-lifesciences-spring.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Sep 2021 |
151 days |
|
![leapta-construction.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/D2waBORKPI5MW9Td/leapta-construction.com) |
leapta-construction.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![leapta-healthcare.com](https://d3dpwkknyrpnnn.cloudfront.net/serve/0qAoWOOT130U0jVL/leapta-healthcare.com) |
leapta-healthcare.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![macrophage-directed-therapies.com](https://d363qos3mhnap4.cloudfront.net/serve/vvbPEPICcwScBxpe/macrophage-directed-therapies.com) |
macrophage-directed-therapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![microbiome-infant-health.com](https://d363qos3mhnap4.cloudfront.net/serve/oJ9kTACOahWY4aIZ/microbiome-infant-health.com) |
microbiome-infant-health.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![mitochondria-targets.com](https://d363qos3mhnap4.cloudfront.net/serve/m6cTWACKRoAwgwu0/mitochondria-targets.com) |
mitochondria-targets.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![mrnabased-therapeutics-europe.com](https://d363qos3mhnap4.cloudfront.net/serve/6owbWOMPnADID9w9/mrnabased-therapeutics-europe.com) |
mrnabased-therapeutics-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Sep 2021 |
Feb 2022 |
127 days |
|
![nash-europe.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/MgacWOOTcXUBzzcP/nash-europe.com) |
nash-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![neoantigen-europe.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/Ut4aWOOTSsdHJYr6/neoantigen-europe.com) |
neoantigen-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![oncolytic-virotherapy-summit.com](https://dbuflkpcdpfh3.cloudfront.net/serve/jiMFZOOPG7lWzibC/oncolytic-virotherapy-summit.com) |
oncolytic-virotherapy-summit.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
May 2021 |
Feb 2022 |
252 days |
|
![pfs-injectables.com](https://d1nywwyphm5jsu.cloudfront.net/serve/ZzeqBONKFv0ovsh4/pfs-injectables.com) |
pfs-injectables.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![predict-innovation-immunotherapies.com](https://d1nywwyphm5jsu.cloudfront.net/serve/prwMYEETVvt7ZtgC/predict-innovation-immunotherapies.com) |
predict-innovation-immunotherapies.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Oct 2021 |
Oct 2021 |
One Off |
|
![prefab-connect.com](https://d1nywwyphm5jsu.cloudfront.net/serve/isCUWOMPKAXRsgav/prefab-connect.com) |
prefab-connect.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|
![dermatology-drugdevelopment-europe.com](https://d3c1mi4ekssrlm.cloudfront.net/serve/eqPdWACK6W73OlzU/dermatology-drugdevelopment-europe.com) |
dermatology-drugdevelopment-europe.com
|
|
Attribute Value |
First Detected |
Last Detected |
Overlap Duration |
|
PD-449062 |
Apr 2021 |
Feb 2022 |
286 days |
|